Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Monica Guffanti
Switching to Unboosted Atazanavir Improves Glucose Tolerance in Highly Pretreated HIV-1 Infected Subjects
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
No Difference in Effectiveness of Treatment Simplification to Boosted or Unboosted Atazanavir Plus Lamivudine in Virologically Suppressed in HIV-1-infected Patients
PLoS ONE
Multidisciplinary
External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients
AAPS Journal
Pharmaceutical Science
High-Carbohydrate–low-Glycaemic Index Dietary Advice Improves Glucose Disposition Index in Subjects With Impaired Glucose Tolerance
British Journal of Nutrition
Medicine
Nutrition
Dietetics
Height and Glucose Tolerance in Adult Subjects
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Safety of Darunavir and Atazanavir in HIV-infected Children in Europe and Thailand
Antiviral Therapy
Infectious Diseases
Pharmacology
Dyslipidemia in HIV-1 Infected Subjects With Short Term Usage of Highly Active Antiretroviral Therapy (HAART) in Benin City, Nigeria
Nigerian Journal of Basic and Applied Sciences
Effector Mechanisms in HIV-1 Infected Elite Controllers: Highly Active Immune Responses?
Antiviral Research
Virology
Pharmacology
Raltegravir With Unboosted Atazanavir 300 Mg Twice Daily in Antiretroviral Treatment-Experienced Participants
Journal of the International Association of Physicians in AIDS Care
Hyperbilirubinemia in Atazanavir Treated HIV-infected Patients: The Impact of the UGT1A1*28 Allele
Pharmacogenomics and Personalized Medicine
Molecular Medicine
Pharmacology
